Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

METAHYDRIN

TRICHLORMETHIAZIDE

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview METAHYDRIN is listed in Drugs@FDA under application 012594 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TRICHLORMETHIAZIDE Form and strength TABLET;ORAL - 2MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1994-01-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview METAHYDRIN is listed in Drugs@FDA under application 012594 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRICHLORMETHIAZIDE Form and strength TABLET;ORAL - 2MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1994-01-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.